Eastern Equine Encephalitis - Pipeline Review, H2 2014 On 30th January 2015
Summary Eastern Equine Encephalitis - Pipeline Review, H2 2014, provides an overview of the Eastern Equine Encephalitiss therapeutic pipeline. This report provides comprehensive information on the therapeutic development for Eastern Equine Encephalitis, complete with comparative analysis at various stages, therapeutics assessment by drug target, mechanism of action (MoA), route of administration (RoA) and molecule type, along with latest updates, and featured news and press releases. It also reviews key players involved in the therapeutic development for Eastern Equine Encephalitis and special features on late-stage and discontinued projects. Global Markets Directs report features investigational drugs from across globe covering over 20 therapy areas and nearly 3,000 indications. The report is built using data and information sourced from Global Markets Directs proprietary databases, Company/University websites, SEC filings, investor presentations and featured press releases from company/university sites and industry-specific third party sources, put together by Global Markets Directs team. Drug profiles/records featured in the report undergoes periodic updation following a stringent set of processes that ensures that all the profiles are updated with the latest set of information. Additionally, processes including live news & deals tracking, browser based alert-box and clinical trials registries tracking ensure that the most recent developments are captured on a real time basis. Email ID- contact@jsbmarketresearch.com Tel No- 91 2241236650 Published by- http:/www.jsbmarketresearch.com/
The report enhances decision making capabilities and help to create effective counter strategies to gain competitive advantage. It strengthens R&D pipelines by identifying new targets and MOAs to produce first-in-class and best-in-class products. Note*: Certain sections in the report may be removed or altered based on the availability and relevance of data for the indicated disease.
Browse Full Report @ http://www.jsbmarketresearch.com/healthcare-medical/r-eastern-equineencephalitis-pipeline-review-h2-2014-151308
Scope - The report provides a snapshot of the global therapeutic landscape of Eastern Equine Encephalitis - The report reviews key pipeline products under drug profile section which includes, product description, MoA and R&D brief, licensing and collaboration details & other developmental activities - The report reviews key players involved in the therapeutics development for Eastern Equine Encephalitis and enlists all their major and minor projects - The report summarizes all the dormant and discontinued pipeline projects - A review of the Eastern Equine Encephalitis products under development by companies and universities/research institutes based on information derived from company and industryspecific sources - Pipeline products coverage based on various stages of development ranging from preregistration till discovery and undisclosed stages - A detailed assessment of monotherapy and combination therapy pipeline projects - Coverage of the Eastern Equine Encephalitis pipeline on the basis of target, MoA, route of administration and molecule type - Latest news and deals relating related to pipeline products Reasons to buy Email ID- contact@jsbmarketresearch.com Tel No- 91 2241236650 Published by- http:/www.jsbmarketresearch.com/
- Provides strategically significant competitor information, analysis, and insights to formulate effective R&D development strategies - Identify emerging players with potentially strong product portfolio and create effective counter-strategies to gain competitive advantage - Develop strategic initiatives by understanding the focus areas of leading companies - Identify and understand important and diverse types of therapeutics under development for Eastern Equine Encephalitis - Plan mergers and acquisitions effectively by identifying key players of the most promising pipeline - Devise corrective measures for pipeline projects by understanding Eastern Equine Encephalitis pipeline depth and focus of Indication therapeutics - Develop and design in-licensing and out-licensing strategies by identifying prospective partners with the most attractive projects to enhance and expand business potential and Scope - Modify the therapeutic portfolio by identifying discontinued projects and understanding the factors that drove them from pipeline
Other industries we cover: • • • • • • • • •
Advertising and Media Automotive and Parts Consumer Goods Healthcare and Medical Finance and Banking Food and Beverages Travel and Tourism Textiles and Clothing SWOT Analysis
Email ID- contact@jsbmarketresearch.com Tel No- 91 2241236650 Published by- http:/www.jsbmarketresearch.com/
Table of Content List of Tables 3 List of Figures 3 Introduction 4 Global Markets Direct Report Coverage 4 Eastern Equine Encephalitis Overview 5 Therapeutics Development 6 Pipeline Products for Eastern Equine Encephalitis - Overview 6 Pipeline Products for Eastern Equine Encephalitis - Comparative Analysis 7 Eastern Equine Encephalitis - Therapeutics under Development by Companies 8 Eastern Equine Encephalitis - Therapeutics under Investigation by Universities/Institutes 9 Eastern Equine Encephalitis - Pipeline Products Glance 10 Clinical Stage Products 10 Early Stage Products 11 Eastern Equine Encephalitis - Products under Development by Companies 12 Eastern Equine Encephalitis - Products under Investigation by Universities/Institutes 13 Eastern Equine Encephalitis - Companies Involved in Therapeutics Development 14 AlphaVax, Inc. 14 AltraVax Inc. 15 EpiVax, Inc. 16 Profectus BioSciences, Inc. 17 Eastern Equine Encephalitis - Therapeutics Assessment 18 Assessment by Monotherapy Products 18 Assessment by Target 19 Assessment by Route of Administration 20 Assessment by Molecule Type 21 Drug Profiles 23 equine encephalitis vaccine - Drug Profile 23 Product Description 23 Mechanism of Action 23 R&D Progress 23 equine encephalitis vaccine - Drug Profile 24 Product Description 24 Mechanism of Action 24 R&D Progress 24 Email ID- contact@jsbmarketresearch.com Tel No- 91 2241236650 Published by- http:/www.jsbmarketresearch.com/
equine encephalitis vaccine - Drug Profile 25 Product Description 25 Mechanism of Action 25 R&D Progress 25 equine encephalitis vaccine - Drug Profile 26 Product Description 26 Mechanism of Action 26 R&D Progress 26 TSI-GSD-104 - Drug Profile 27 Product Description 27 Mechanism of Action 27 R&D Progress 27 Eastern Equine Encephalitis - Dormant Projects 28 Appendix 29 Methodology 29 Coverage 29 Secondary Research 29 Primary Research 29 Expert Panel Validation 29 Contact Us 30 Disclaimer 30 List Of Tables Number of Products under Development for Eastern Equine Encephalitis, H2 2014 6 Number of Products under Development for Eastern Equine Encephalitis - Comparative Analysis, H2 2014 7 Number of Products under Development by Companies, H2 2014 8 Number of Products under Investigation by Universities/Institutes, H2 2014 9 Comparative Analysis by Clinical Stage Development, H2 2014 10 Comparative Analysis by Early Stage Development, H2 2014 11 Products under Development by Companies, H2 2014 12 Products under Investigation by Universities/Institutes, H2 2014 13 Eastern Equine Encephalitis - Pipeline by AlphaVax, Inc., H2 2014 14 Eastern Equine Encephalitis - Pipeline by AltraVax Inc., H2 2014 15 Eastern Equine Encephalitis - Pipeline by EpiVax, Inc., H2 2014 16 Email ID- contact@jsbmarketresearch.com Tel No- 91 2241236650 Published by- http:/www.jsbmarketresearch.com/
Eastern Equine Encephalitis - Pipeline by Profectus BioSciences, Inc., H2 2014 17 Assessment by Monotherapy Products, H2 2014 18 Number of Products by Stage and Target, H2 2014 19 Number of Products by Stage and Route of Administration, H2 2014 20 Number of Products by Stage and Molecule Type, H2 2014 22 Eastern Equine Encephalitis - Dormant Projects, H2 2014 28 List Of Figures Number of Products under Development for Eastern Equine Encephalitis, H2 2014 6 Number of Products under Development for Eastern Equine Encephalitis - Comparative Analysis, H2 2014 7 Number of Products under Development by Companies, H2 2014 8 Comparative Analysis by Early Stage Products, H2 2014 11 Assessment by Monotherapy Products, H2 2014 18 Number of Products by Top 10 Molecule Types, H2 2014 21 Number of Products by Stage and Top 10 Molecule Types, H2 2014 22
Report Price: Licence Type
Price
$ 2000
Site License
$ 4000
Enterprise Wide Licence
$ 6000
Related Reports: Global Neurosurgery Market 2015-2019 Global Ankylosing Spondylitis Market 2015-2019 Epilepsy Market in the US 2015-2019 Global Preclinical Imaging Market 2015-2019 Sickle-cell Anemia Therapeutics Market in the US 2015-2019 Healthcare RCM Outsourcing Market in the US 2015-2019 Medical Technologies Market in the APAC Region 2015-2019 Email ID- contact@jsbmarketresearch.com Tel No- 91 2241236650 Published by- http:/www.jsbmarketresearch.com/
Active Pharmaceutical Ingredients (API) Market in India 2015-2019 Cochlear Implants Market in the US 2015-2019 Global Anxiety Disorders Market 2015-2019
You can order this report by calling on +91 - 998 7295 242 or mail us your contact details at contact@jsbmarketresearch.com About JSB Market Research:JSB market research is a leading player in the market of research report distribution. It is onestop-shop for all information related to market research for any sector of the industry. Along with providing in-depth analysis though reports, JSB market research also provides regular updates of the market though newsletters. Our reports are a well-researched work of market researchers with an extensive knowledge and a good level of market experience.
To know more on Eastern Equine Encephalitis - Pipeline Review, H2 2014
http://www.jsbmarketresearch.com/healthcare-medical/r-easternequine-encephalitis-pipeline-review-h2-2014-151308
Email ID- contact@jsbmarketresearch.com Tel No- 91 2241236650 Published by- http:/www.jsbmarketresearch.com/